Abstract: A vehicle-mounted communication system is provided. The communication system includes a communication device. The communication device includes at least a plurality of displays that are mounted on top of a vehicle. Each display includes a smoky acrylic covering for hiding one or more dead pixels. Based on real-time status of the vehicle, a driver of the vehicle, or a passenger therein, the communication device obtains targeted content and displays the targeted content on the plurality of displays for communicating relevant information to various prospective passengers for their rides or other near-by individuals who can offer help in case of any emergency.

Abstract: The present invention relates to a method of cloning stable stress tolerant superoxide dismutase from diverse plant species using universal primers.

Abstract: Compounds having the structure or their salts: are used to treat or reduce le likelihood of acquiring androgen-dependent diseases, such as prostate cancer, benign prostatic hyperplasia, polycystic ovarian syndrome, acne, hirsutism, seborrhea, androgenic alopecia and male baldness. They can be formulated together with pharmaceutically acceptable diluent or carrier or otherwise made into any pharmaceutical dosage form. Some of these compounds having tissue-specific antiandrogenic activity and tissue-specific androgenic activity can be used to treat or reduce the risk of developing diseases related to loss of androgenic stimulation. Combinations with other active pharmaceutical agents are also disclosed.

Abstract: Embodiments of the invention provide an injection guide for stabilizing an injection site located on an ocular structure during an intravitreal injection. The injection guide includes a first flange positioned opposite a second flange. The first and second flanges can hold portions of the ocular structure away from the injection site. The injection guide can include a handle coupled to the second flange and positioned away from the injection site to provide a substantially unobstructed view of the injection site and the ocular structure. A base plate can be positioned between and coupled to the first and second flange. The base plate includes an aperture or a notch positioned a predetermined distance from an edge of the base plate to provide 360 degree access to the injection site. The base plate can include a tamponade surface configured to tamponade the ocular structure after the intravitreal injection.

Abstract: The present invention provides dimethyl sulphoxide solvate of 4-(4-{3-[4-chloro-3 -(trifluoromethyl)phenyl]ureido}phenoxy)-N2-methylpyridine-2-carboxamide, process for its preparation, pharmaceutical composition comprising it and its use for the treatment of cancer. The present invention also provides a novel HPLC method for the identification, quantification and isolation of related substances of sorafenib.

Abstract: The present invention relates to a method of cloning stable stress tolerant superoxide dismutase from diverse plant species using universal primers.

Abstract: In the semi-arid region, particularly in hard rock terrain, shallow aquifers are major source of potable groundwater. These aquifers are indiscriminately exploited to meet the growing demand of water for domestic, irrigation as well as industrial use. In order to achieve a sustainable development, it is essential not only to delineate the groundwater potential zone and but also suitable augmentation scheme which in turn requires delineation of feasible recharge zone. Such zones are conventionally delineated through the application of various indirect methods such as hydro-geomorphological, geological and geophysical, which many times are time consuming and uneconomical. A simple, efficient and cost-effective cross correlation based process which takes into consideration the study of aquifer response to rainfall is provided in the present invention to delineate groundwater recharge zone.

Abstract: Compounds having the structure (or their salts): are used to treat or reduce the likelihood of acquiring androgen-dependent diseases, such as prostate cancer, benign prostatic hyperplasia, polycystic ovarian syndrome, acne, hirsutism, seborrhea, androgenic alopecia and male baldness. The compounds can be formulated together with pharmaceutically acceptable diluents or carriers or otherwise made into any pharmaceutical dosage form. Combinations with other active pharmaceutical agents are also disclosed.

Abstract: Compounds having the structure or their salts: are used to treat or reduce le likelihood of acquiring androgen-dependent diseases, such as prostate cancer, benign prostatic hyperplasia, polycystic ovarian syndrome, acne, hirsutism, seborrhea, androgenic alopecia and male baldness. They can be formulated together with pharmaceutically acceptable diluent or carrier or otherwise made into any pharmaceutical dosage form. Some of these compounds having tissue-specific antiandrogenic activity and tissue-specific androgenic activity can be used to treat or reduce the risk of developing diseases related to loss of androgenic stimulation. Combinations with other active pharmaceutical agents are also disclosed.